Canada ready to give ground to EU on drug patent protection: sources

As free trade talks with the European Union reach the endgame, Ottawa is signalling it is prepared to give the Europeans at least part of what they asked for on drug patents — a move that could cost Canadians up to $900 million a year.

A subscription is needed to view the rest of this content, Register or log in to add or update your subscription